DAVID MOATAZEDI - 07 Mar 2025 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jeffrey J. Plumer, as attorney-in-fact for David Moatazedi
Issuer symbol
EOLS
Transactions as of
07 Mar 2025
Transactions value $
$0
Form type
4
Filing time
11 Mar 2025, 18:54:41 UTC
Previous filing
26 Dec 2024
Next filing
20 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock Award $0 +95,399 +18.2% $0.000000 618,246 07 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EOLS Performance Restricted Stock Units Award $0 +190,799 $0.000000 190,799 07 Mar 2025 Common Stock 190,799 Direct F2, F3
transaction EOLS Stock Option (Right to Buy) Award $0 +135,925 $0.000000 135,925 07 Mar 2025 Common Stock 135,925 $13.58 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.
F2 Each performance-based restricted stock unit ("PSU") represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.
F3 The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.
F4 The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Remarks:

President and Chief Executive Officer